Product Switch Grant
After approval by GAVI for a specific type of vaccine support, a country may later wish to switch to a different presentation of the vaccine with the same antigen, e.g. from lyophilised pentavalent to liquid pentavalent, or from a one-dose to 10-dose vial format. To facilitate the transition to a different presentation, and if certain criteria are met, countries can apply for an additional grant to help cover the costs associated with the product switch.
- ID Projet
47122-18-UGA-25A-Y- Statut de l'activité
- 2 - Implementation
- Type d'aide
- B02 - Contributions aux budgets réguliers des institutions multilatérales
- % to Ouganda
- 100.00
Organisations
- Funding
- The Global Alliance for Vaccination and Immunisation
- Extending
- World Health Organisation - core voluntary contributions account (for technical assitance)
- Accountable
- Federal States & Local Governments
- Implementing
- Federal States & Local Governments
Versements par exercice fiscal, trimestre
| Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Ouganda Montant (USD) |
Engagements par exercice fiscal, trimestre
| Exercice fiscal |
Trimestre fiscal |
Montant (USD) |
Ouganda Montant (USD) |
| 2017 |
Q3 |
470,533.00 |
470,533.00 |
Projections de CDMT par exercice fiscal
| Exercice fiscal |
Montant (USD) |
Ouganda Montant (USD) |
| 2018 |
235,266.50 |
235,266.50 |
| 2017 |
235,266.50 |
235,266.50 |
| Code CRS |
% |
|
Soins et services de santé de base
(12220)
|
100.0
|